Susan Kelley
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Susan L.
Kelley is currently Director at Deciphera Pharmaceuticals LLC since 2019, Independent Director at Daré Bioscience, Inc. since 2014, and Director at A2 Biotherapeutics, Inc. Former roles include Independent Director at ArQule, Inc. from 2011 to 2020, Independent Non-Executive Director at The Sustainable Nutrition Group Pty Ltd. from 2013 to 2015, Director at Audeo Oncology, Inc. in 2012, Independent Director at IDEAYA Biosciences, Inc. from 2021 to 2025, Independent Director at Cerulean Pharma, Inc. from 2014 to 2017, Executive Director-Oncology Clinical Research at Bristol-Myers Squibb World Wide Medicines Group from 1987 to 2001, Independent Non-Executive Director at Vascular Biogenics Ltd. from 2011 to 2020, Independent Director at Immune Design Corp.
from 2016 to 2019, Executive Director at Oncology Clinical Research & Development in 2001, Independent Director at Deciphera Pharmaceuticals, Inc. from 2019 to 2024, Vice President-Global Clinical Development at Bayer Pharma AG and Bayer HealthCare Pharmaceuticals, Inc. in 2008, Chief Medical Officer at Multiple Myeloma Research Consortium from 2008 to 2011, and Assistant Professor at Yale School of Medicine.
Education includes undergraduate degree from Colgate University and doctorate from Duke University School of Medicine.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| DARÉ BIOSCIENCE, INC. | Directeur/Membre du Conseil | 01/10/2014 |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Discovers and develops pharmaceutical preparations | Directeur/Membre du Conseil | 01/07/2019 |
A2 Biotherapeutics, Inc.
A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell therapies for cancer treatment | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 24/06/2025 |
| DECIPHERA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 11/06/2024 |
| ARQULE, INC. | Directeur/Membre du Conseil | 16/01/2020 |
| NOTABLE LABS, LTD. | Directeur/Membre du Conseil | 01/01/2020 |
| IMMUNE DESIGN CORP | Directeur/Membre du Conseil | 02/04/2019 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 21 |
|---|---|
ArQule, Inc.
ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Bayer Schering Pharma AG
Bayer Schering Pharma AG Medical SpecialtiesHealth Technology Manufactures pharmaceuticals and diagnostic substances | Health Technology |
The Sustainable Nutrition Group Pty Ltd.
The Sustainable Nutrition Group Pty Ltd. Agricultural Commodities/MillingProcess Industries Produces, manufactures and sells hemp products | Process Industries |
Audeo Oncology, Inc.
Audeo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Provides cancer treatment services | Health Technology |
Colgate University
Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Design and develops nanopharmaceuticals | Health Technology |
Bristol-Myers Squibb World Wide Medicines Group
Bristol-Myers Squibb World Wide Medicines Group Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Bayer HealthCare Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Health Technology |
Multiple Myeloma Research Consortium
Multiple Myeloma Research Consortium Miscellaneous Commercial ServicesCommercial Services Provides research and drug development | Commercial Services |
Bristol-Myers Squibb Pharmaceutical Research Institute | |
Vascular Biogenics Ltd.
Vascular Biogenics Ltd. BiotechnologyHealth Technology Develops novel treatments for atherosclerosis and cancer | Health Technology |
Immune Design Corp.
Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Discovers and develops pharmaceutical preparations | Health Technology |
Oncology Clinical Research & Development | |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University School of Medicine
Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
Daré Bioscience, Inc.
Daré Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Deciphera Pharmaceuticals, Inc.
Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drug candidates to improve the lives of cancer patients | Health Technology |
A2 Biotherapeutics, Inc.
A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell therapies for cancer treatment | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national